Lead Product(s): Quetiapine Fumarate
Therapeutic Area: Psychiatry/Psychology
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Cipla Medpro
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement February 10, 2020
Luye Pharma granted the distribution and marketing rights to Cipla Medpro in South Africa and neighbouring countries on the basis of its robust business network and resources in local markets.